SEC Form 4 · accession 0001022079-15-000059
QUEST DIAGNOSTICS INC · DGX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Michael E Prevoznik
Officer — SVP & General Counsel
Period of report
Feb 27, 2015
Accepted (ET)
Mar 3, 2015 · 6:29 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001022079
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Feb 27, 2015 | F | 492 | $71.25 | D | 46,128 | D | |
| Common StockF1 | Mar 2, 2015 | F | 925 | $70.53 | D | 45,203 | D | |
| Common StockF2 | Mar 2, 2015 | A | 189 | $0.00 | A | 45,392 | D | |
| Common StockF3 | Mar 2, 2015 | F | 71 | $70.53 | D | 45,321 | D | |
| Common StockF5,F6 | Mar 3, 2015 | S | 3,261 | $71.157 | D | 42,067 | D | |
| Common StockF7 | holding | — | — | — | 4,614 | I | 401(k)/SDCP |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the vesting of a previous grant of restricted share units.
- F2Stock issued by Quest Diagnostics Incorporated in settlement of a performance share award dated February 27, 2012, approved in accordance with the requirements of Rule 16b-3(d).
- F3Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the settlement of said performance share award.
- F4The sale reported was effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on May 8, 2014.
- F5This transaction was executed in multiple trades at prices ranging from $71.09 to $71.23. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F6The amount includes exempt purchases made under the Company's stock purchase plan since the date of the last filing on Form 4.
- F7These underlying shares were acquired on a periodic basis by the trustee of the Company's tax qualified Profit Sharing (401(k)) and/or Supplemental Deferred Compensation Plan. The information was obtained from the plan administrator as of a current date. The number of shares is based on the account balance of the Company stock fund under each Plan (which includes some money market instruments) divided by the market price of the Company's stock as of that date.